Double the Double: Revisiting BCL11B's Multimerization

Area of Science:

• Molecular Biology
• Immunology
• Structural Biology

Background:

• B Cell Lymphoma/Leukemia 11B (BCL11B) is a transcription factor with a bi-directional role in cancer.
• BCL11B's function is crucial for innate versus adaptive immune regulation, as indicated by T cell knockout studies showing natural killer cell properties.
• Previous research suggested BCL11B forms dimers, a prerequisite for its activity.

Purpose of the Study:

• To investigate the multimerization state of BCL11B.
• To reconcile conflicting experimental data regarding BCL11B's oligomeric form.
• To elucidate the structural basis of BCL11B multimerization for therapeutic targeting.

Main Methods:

• Förster Resonance Energy Transfer-assisted Fluorescence-Activated Cell Sorting (FRET-FACS)
• Hybrid Solvent Replica-Exchange Simulations
• Size Exclusion Chromatography
• Crosslinking Experiments

Main Results:

• Experimental data suggested BCL11B forms tetramers, challenging prior dimer models.
• A novel 3D structure of BCL11B was determined using extensive replica-exchange simulations.
• The atypical CCHC zinc finger motif in the N-terminal region mediates BCL11B multimerization.
• Simulated structures strongly agreed with experimental findings.

Conclusions:

• BCL11B multimerization, mediated by its zinc finger motif, is critical for its function.
• Understanding BCL11B's tetrameric structure provides a basis for developing targeted cancer therapies.
• This research opens avenues for novel therapeutic strategies against cancer.